Several studies [18,21] have shown that EGFR mutations are mostly seen in patients with lung adenocarcinoma without a smoking history, that female, of the peripheral type, and are not associated with factors such as age and pathological stage, which are further validated in our current study. This evidence concerns the gene EGFR and lung adenocarcinoma.